Welcome to Alteron Therapeutics

FOCUSED ON THE CURE

Alteron is dedicated to achieving one of the most ambitious goals of 21st century medicine: curing Alzheimer’s disease and ALS

people, old, man

Harnessing the power of The central nervous system

Alteron Therapeutics focuses on the clinical development of TDP-43 inhibitors for the treatment of cystic fibrosis and neurodegenerative disorders like Alzheimer’s and ALS.

Our ALT drugs: are first-in-class TDP-43 inhibiting drugs; block TDP-43 nucleic acid binding; can penetrate blood-brain barrier; have shown efficacy in a disease model

Chengliang Zhang,

Founder, CEO of Alteron Therapeutics

Our Technology

Our industry-leading cell therapy technology uses the power of a person’s own immune system to target and attacks their tumors. This is accomplished through the use of genetically modified T cells that can increase the number of tumor-specific T cells and strengthen the body’s ability to kill certain types of cancer cells.

Pathologycam Testing

Nulla viverra egestas sapien mollis a molest ullamcorper aenean.

Mineral Assay

Magna non in suspendisse arcu, lacus ut euismod arcu velit amet lacinia.

Pharmaceutical Research

Est velit cursus eu in amet tortor, in egestas tortor euismod diam.

Why People Trust Us

Id elit mauris neque, purus dui turpis gravida id viverra nunc sit risus quam ornare et massa viverra porta risus justo lectus morbi pulvinar non bibendum nisl quisque donec nunc facilisis fermentum.

High Quality Lab

In iaculis nisi, a tempor diam luctus elit vulputate aliquet proin tincidunt

Unmatched Expertise

In iaculis nisi, a tempor diam luctus elit vulputate aliquet proin tincidunt

Precise Result

In iaculis nisi, a tempor diam luctus elit vulputate aliquet proin tincidunt

Qualified Staff

In iaculis nisi, a tempor diam luctus elit vulputate aliquet proin tincidunt

Our Partnership

Latest Studies

Latest research studies in Alzheimer’s Disease, Lou Gehrig’s Disease, Cystic Fibrosis, Frontotemporal Lobar Degeneration.

Alteron Expert Team

Chengliang Zhang

Co-Founder of Alteron Therapeutics

Chandler Fang

Co-Founder of Alteron Therapeutics

Xinchun Zhang

Co-Founder of Alteron Therapeutics

Our Research Focus

Alzheimer’s Disease

Lou Gehrig’s Disease

Cystic Fibrosis

Frontotemporal Lobar Degeneration

Our Facilities

Innovation Center
WMU Homer Stryker M.D. School of Medicine

Our Location

4717 Campus Dr, Ste 1000 Kalamazoo, MI 49008

Contact Us

Urna aliquet feugiat odio enim ut pharetra pretium velit viverra elementum pulvinar viverra diam urna rhoncus eu, et, malesuada luctus neque mollis morbi placerat.

ir@alterontx.com